Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Quality And Purity Of Popular Stevia Sweetener Strengthened By New Reference Standards
As the number of food and beverage products sweetened with stevia-based ingredients continues to grow in the United States and worldwide, the U.S. Pharmacopeial (USP) Convention announces that new reference standards for Rebaudioside A and Stevioside are now available. The reference standards for these two ingredients complement the soon to be released written testing standard for high-purity Rebaudioside A in the Food Chemicals Codex (FCC), a collection of documentary standards for food ingredients that allow manufacturers to demonstrate the quality, and thus related aspects of safety, of the products they provide to consumers.

Sosei And Vectura Announce Start Of Phase III Clinical Study With NVA237
Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565) and Vectura Group plc ("Vectura"; LSE: VEC) announce the commencement of a Phase III clinical study by Novartis, with NVA237, a once-daily, long-acting muscarinic antagonist (LAMA) for the treatment of chronic obstructive pulmonary disease (COPD). NVA237 is a dry powder formulation for oral inhalation of glycopyrronium bromide, a LAMA with a rapid onset of activity. The study has now appeared on clinicaltrials.gov and will be recruiting in the next few weeks when the first patient first visit will trigger a $7.5 million milestone payment to both Sosei and Vectura.
News of the day
Royal Pharmaceutical Society of Great Britain's Council Officers For 2009/10 Elected
The Royal Pharmaceutical Society of Great Britain"s incumbent President, Steve Churton has
Cardiovascular

Man Charged With Murder Of Abortion Provider Tiller Pleads Not Guilty

Scott Roeder, the man charged with the May 31 shooting death of abortion provider George Tiller, pleaded not guilty to first-degree murder and aggravated assault at a Wichita, Kan., hearing on Tuesday, the AP/Boston Globe reports (AP/Boston Globe, 7/29). After witnesses described events surrounding the shooting, the judge presiding over the hearing concluded that there was sufficient evidence to try Roeder. Tiller was murdered in the foyer of his church, where he was serving as an usher. According to several church members who testified Tuesday, Roeder occasionally had come to the church in the months before the shooting.The trial is scheduled to begin Sept. 21 (Davey, New York Times, 7/28). At the hearing, Roeder made no public comments, and the not-guilty plea was entered by the public defender representing him in the case (AP/Boston Globe, 7/29).If convicted, Roeder likely will face life in prison, as the case does not meet state criteria for the death penalty. His lawyers declined to comment on their defense plans (New York Times, 7/28). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009